trial · primary record
KM-023
Pachyonychia Congenita
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2027-11 |
| Primary endpoint | To assess the safety of repeated doses of oral KM-023 in individuals with PC. |
| Registry ID | NCT07893483 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:55.199Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07893483
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.